Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5305847018 | Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5305848011 | Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium bicarbonate 26.7 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5305849015 | Calcium carbonate 16 mg/mL and sodium alginate 50 mg/mL and sodium hydrogen carbonate 26.7 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Calcium carbonate and sodium alginate and sodium bicarbonate only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Calcium carbonate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Calcium carbonate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Sodium bicarbonate (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Sodium bicarbonate (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Sodium alginate | true | Inferred relationship | Some | 3 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Sodium alginate | true | Inferred relationship | Some | 3 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
| Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR